Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy.

Neurona Therapeutics has gained $102m to support the advancement of its investigational cell therapy, NRTX-1001, into Phase III testing for drug-resistant mesial temporal lobe epilepsy (MTLE). The ...

Researchers identified walking impairment and malarial disease sustained by Tutankhamun, supported by the discovery of canes and an afterlife pharmacy in his tomb.

In a groundbreaking discovery, scientists have found that the birth of new brain cells in adults plays a key role in verbal ...

More information: Vaclav Kremen et al, Modulating limbic circuits in temporal lobe epilepsy: impacts on seizures, memory, mood and sleep, Brain Communications (2025). DOI: 10.1093/braincomms ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

These cases suggest that good seizure control after a successful ... that have contributed to suicidality. Frontal and temporal lobe networks and changes in serotonergic activity have been ...

Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus. In a ...